ITVR20000038A1 - FUNCTIONAL FOOD PRODUCTS. - Google Patents
FUNCTIONAL FOOD PRODUCTS. Download PDFInfo
- Publication number
- ITVR20000038A1 ITVR20000038A1 IT2000VR000038A ITVR20000038A ITVR20000038A1 IT VR20000038 A1 ITVR20000038 A1 IT VR20000038A1 IT 2000VR000038 A IT2000VR000038 A IT 2000VR000038A IT VR20000038 A ITVR20000038 A IT VR20000038A IT VR20000038 A1 ITVR20000038 A1 IT VR20000038A1
- Authority
- IT
- Italy
- Prior art keywords
- powder
- general
- omega3
- shii
- lecithin
- Prior art date
Links
- 235000013376 functional food Nutrition 0.000 title description 3
- 239000008347 soybean phospholipid Substances 0.000 claims description 14
- 240000000599 Lentinula edodes Species 0.000 claims description 11
- 235000001715 Lentinula edodes Nutrition 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 claims description 8
- 229920001661 Chitosan Polymers 0.000 claims description 8
- 229920002581 Glucomannan Polymers 0.000 claims description 8
- 229940046240 glucomannan Drugs 0.000 claims description 8
- 229920001202 Inulin Polymers 0.000 claims description 7
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 7
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 7
- 239000000835 fiber Substances 0.000 claims description 7
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 7
- 229940029339 inulin Drugs 0.000 claims description 7
- 229960004999 lycopene Drugs 0.000 claims description 7
- 235000012661 lycopene Nutrition 0.000 claims description 7
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 7
- 239000001751 lycopene Substances 0.000 claims description 7
- 235000013322 soy milk Nutrition 0.000 claims description 7
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 6
- 235000008429 bread Nutrition 0.000 claims description 4
- 235000015927 pasta Nutrition 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 244000298479 Cichorium intybus Species 0.000 claims description 3
- 235000007542 Cichorium intybus Nutrition 0.000 claims description 3
- 240000007472 Leucaena leucocephala Species 0.000 claims description 3
- 235000010643 Leucaena leucocephala Nutrition 0.000 claims description 3
- 239000008188 pellet Substances 0.000 claims description 3
- 235000013550 pizza Nutrition 0.000 claims description 3
- 235000013606 potato chips Nutrition 0.000 claims description 3
- 244000061456 Solanum tuberosum Species 0.000 claims 4
- 235000002595 Solanum tuberosum Nutrition 0.000 claims 2
- 229940045110 chitosan Drugs 0.000 claims 2
- 235000020688 green tea extract Nutrition 0.000 claims 2
- 235000008371 tortilla/corn chips Nutrition 0.000 claims 2
- 235000013305 food Nutrition 0.000 description 17
- 230000009471 action Effects 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 229940067606 lecithin Drugs 0.000 description 7
- 235000010445 lecithin Nutrition 0.000 description 7
- 239000000787 lecithin Substances 0.000 description 7
- 244000269722 Thea sinensis Species 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 235000009569 green tea Nutrition 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 239000000825 pharmaceutical preparation Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 150000003626 triacylglycerols Chemical class 0.000 description 4
- 235000010469 Glycine max Nutrition 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- 230000003627 anti-cholesterol Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 235000021323 fish oil Nutrition 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000031891 intestinal absorption Effects 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 150000002515 isoflavone derivatives Chemical class 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 2
- 229940012843 omega-3 fatty acid Drugs 0.000 description 2
- 239000006014 omega-3 oil Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001112696 Clostridia Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 238000008214 LDL Cholesterol Methods 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 235000021324 borage oil Nutrition 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Chemical class OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000021185 dessert Nutrition 0.000 description 1
- 235000011850 desserts Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 229940033080 omega-6 fatty acid Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 210000003254 palate Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000011049 pearl Substances 0.000 description 1
- 229930195732 phytohormone Natural products 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 230000037321 sleepiness Effects 0.000 description 1
- 229940071440 soy protein isolate Drugs 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Landscapes
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Description
TITOLO: Prodotti alimentari funzionali TITLE: Functional food products
2. Principi attivi 2. Active ingredients
Nella scelta e nella ricerca dei principi attivi si sono adottati diversi criteri selettivi come, stabilità, compatibilità sia tra gli stessi che con gli alimenti, funzionalità e sinergie, e non ultimo la palatabilità, owerossia il gusto del prodotto finale. Il nostro concetto è che il cibo debba avere rilevanza salutistica e nel contempo dare soddisfazione al palato ed al gusto del consumatore, cosa non certo facile di per sé data la natura degli estratti. Allo scopo si sono selezionate gli estratti secondo quattro grandi classi funzionali : In the choice and research of the active ingredients, various selective criteria have been adopted such as stability, compatibility both between them and with the foods, functionality and synergies, and last but not least the palatability, or the taste of the final product. Our concept is that food must have health relevance and at the same time give satisfaction to the palate and taste of the consumer, which is certainly not easy in itself given the nature of the extracts. For this purpose, the extracts were selected according to four major functional classes:
a. funzione su colesterolo e trigliceridi to. function on cholesterol and triglycerides
b. funzione su flora batterica ed ambiente intestinale b. function on bacterial flora and intestinal environment
c. funzione sull’ assorbimento intestinale c. function on intestinal absorption
d. funzione antiossidante e protettiva generale. d. antioxidant and general protective function.
Già è possibile evidenziare un primo carattere di novità e di originalità della invenzione: l’individuazione di classi funzionali e loro associazione sinergica. Abbiamo infatti notato come l’associazione tra elementi di classi diverse, abbia come conseguenza un effetto sinergico che si traduce in un incremento dell’ attività biologica, ad una risultato finale apprezzabile e percepibile direttamente dal consumatore, come sensazione di benessere generale, facilità di digestione, ridotta pesantezza e sonnolenza postprandiale, ecc.. Poi si sono ricercati i componenti delle varie classi, di seguito elencati, più adatti al nostro scopo per attività, stabilità, sapori indotti, che unitamente agli alimenti di cui al punto 5 del presente elaborato, costituiscono l’oggetto di questo brevetto: It is already possible to highlight a first character of novelty and originality of the invention: the identification of functional classes and their synergistic association. We have in fact noticed how the association between elements of different classes, has as a consequence a synergistic effect that translates into an increase in biological activity, to an appreciable and perceptible final result directly by the consumer, as a feeling of general well-being, ease of digestion. , reduced heaviness and postprandial sleepiness, etc .. Then we searched for the components of the various classes, listed below, most suitable for our purpose for activity, stability, induced flavors, which together with the foods referred to in point 5 of this paper, constitute the subject of this patent:
A. Azione su colesterolo e trigliceridi A. Action on cholesterol and triglycerides
Al. lecitina di soya A2. latte di soya Al.Soya lecithin A2. soy milk
A3. acidi grassi poiinsaturi Omega3 (estratti e purificati da olio di pesce) A4. acidi grassi poiinsaturi Omega6 (estratti e purificati da olio di borraggine) A3. polyunsaturated Omega3 fatty acids (extracted and purified from fish oil) A4. polyunsaturated Omega6 fatty acids (extracted and purified from borage oil)
A5. shii take (lentinus edodes) in polvere o in estratto A5. shii take (lentinus edodes) in powder or extract
B. Azione su flora batterica ed ambiente intestinale B. Action on bacterial flora and intestinal environment
Bl. fermenti lattici in generale B3. inulina ed oligosaccaridi B4. fibre vegetali solubili di acacia, rapa e cicoria Bl. lactic ferments in general B3. inulin and B4 oligosaccharides. soluble vegetable fibers of acacia, turnip and chicory
C. Azione su assorbimento intestinale C. Action on intestinal absorption
Cl. Chitosano C2. Glucomannano Cl. Chitosan C2. Glucomannan
D. Azione antiossidante e protettiva generale D. Antioxidant and general protective action
DI. Lycopene D2. Tè Verde FROM. Lycopene D2. Green tea
3. Stato attuale delle cose 3. Current state of affairs
Lecitina di soya Soya lecithin
Per quanto riguarda la lecitina di soya essa viene impiegata industrialmente come emulsionante nella fabbricazione di cioccolato, creme, desserts, dolciumi e margarine. E’ presente sul mercato in forme a se stanti ed univoche, come barattoli, pillole, capsule. Si trovano in commercio alimenti di base, come pane o pasta, che contengono farina di soya, o proteine isolate di soya, ma non con i suoi derivati purificati, come la lecitina o il latte di soya. L’uso dei due derivati singolarmente od in associazione costituisce quindi una novità ed un passo avanti rispetto all’ uso della soya in toto come farina negli alimenti proposti. As for soy lecithin, it is used industrially as an emulsifier in the manufacture of chocolate, creams, desserts, sweets and margarines. It is present on the market in separate and unique forms, such as jars, pills, capsules. There are basic foods on the market, such as bread or pasta, which contain soy flour, or soy protein isolate, but not with its purified derivatives, such as lecithin or soy milk. The use of the two derivatives individually or in combination therefore constitutes a novelty and a step forward compared to the use of soya in its entirety as flour in the proposed foods.
Latte di sova Milk of sova
Normalmente presente come bevanda e come componente di qualche dessert o budino. Mai usato da solo o in associazione con lecitina negli alimenti oggetto di questo brevetto. Normally present as a drink and as a component of some dessert or pudding. Never used alone or in combination with lecithin in foods covered by this patent.
Omega3 - Omega6 Omega3 - Omega6
Presenti in preparati tipo perle di gelatina, compresse o capsule, ricalcando quindi la consueta preparazione, forma, presentazione ed uso di tipo erboristico-farmaceutico. L’unico esempio di additivazione alimentare degli Omega3 in prodotti alimentari di largo consumo lo si trova nel latte, alimento comunque non contemplato in questo brevetto. Present in preparations such as gelatin pearls, tablets or capsules, thus tracing the usual herbal-pharmaceutical preparation, form, presentation and use. The only example of Omega3 food additives in widely consumed food products is found in milk, a food not covered by this patent.
Fermenti lattici e Lieviti vivi Lactic ferments and live yeasts
Presenti in preparati di tipo erboristico/farmaceutico. Present in herbal / pharmaceutical preparations.
Impiegati normalmente in additivazione di prodotti da latteria. Normally used in additives to dairy products.
Fibre solubili Soluble fibers
Presenti solo in preparati di tipo erboristico-farmaceutico Present only in herbal-pharmaceutical preparations
Fibre assorbenti Absorbent fibers
II glucomannano ed il chitosano, anch’essi sono normalmente presentati in pillole per diete dimagranti, nella consueta forma erboristico/farmaceutica. Shii Take Glucomannan and chitosan are also normally presented in pills for slimming diets, in the usual herbal / pharmaceutical form. Shii Take
Lo shii take invece viene consumato fresco e allo stato secco come un normale fungo edibile. Shii take, on the other hand, is eaten fresh and dry like a normal edible mushroom.
Lycopene - Tè verde Lycopene - Green tea
Presenti in preparati di uso erbori stico e farmaceutico. Present in herbal and pharmaceutical preparations.
Totalmente assenti negli alimenti di cui al punto 5. Totally absent in the foods referred to in point 5.
4. Novità 4. News
La novità della presente invenzione consiste nella formulazione di prodotti alimentari funzionali, cioè con caratteristiche salutistiche di base oltre che nutrizionali, tramite additivazione di specifici estratti vegetali ed animali, sia singolarmente che in associazione. Si differenziano dai prodotti dietetici in quanto non sono destinati ad un uso specifico, bensì ad un uso generalizzato, senza limitazioni o controindicazioni. The novelty of the present invention consists in the formulation of functional food products, ie with basic health characteristics as well as nutritional ones, by adding specific plant and animal extracts, both individually and in combination. They differ from dietary products in that they are not intended for a specific use, but for general use, without limitations or contraindications.
Senza entrare nel dettaglio, lasciando a chi di dovere l’intervento nei casi conclamati con mezzi di valore terapeutico, non si può di certo sottovalutare l’azione di fondo che alimenti di questo tipo possono esercitare nella prevenzione di alcune malattie cardiovascolari, nel diabete, nelle obesità, nelle ipercolesterolemie e più in generale nel mantenimento di uno stato fisico e mentale ottimale. Without going into detail, leaving the intervention in full-blown cases with means of therapeutic value to those in charge, we certainly cannot underestimate the basic action that foods of this type can exert in the prevention of some cardiovascular diseases, in diabetes, in obesity, hypercholesterolemia and more generally in maintaining an optimal physical and mental state.
5. Prodotti alimentari oggetto dell' intervento 5. Food products object of the intervention
Mai sino ad ora si è pensato ad una pratica alimentare di questo tipo e specificatamente negli alimenti sottoelencati, che risultano anch’essi oggetto di questo brevetto: Never before has a food practice of this type been thought of and specifically in the foods listed below, which are also the subject of this patent:
a. Gnocchi b. Tortellini c. Pizze d. Grissini e. Crackers f. Polenta in polvere o pronta all’uso to. Dumplings b. Tortellini c. Pizzas d. Breadsticks e. Crackers f. Polenta in powder or ready to use
g. Purè in polvere o pronto all’uso h. Chips di patata g. Puree in powder or ready to use h. Potato chips
i. Pellets per chips 1. Pane m. Pasta in generale the. Pellets for chips 1. Bread m. Pasta in general
6. Breve elenco dell’attività biologica dei singoli elementi 6. Short list of the biological activity of the individual elements
6.1 Lecitina di soya 6.1 Soy lecithin
Emulsionante naturale, mantiene in sospensione il colesterolo presente nel sangue impedendo che si depositi sulla parete delle arterie. Abbassa il contenuto di colesterolo LDL nel sangue, che rappresenta il maggior responsabile dell’ insorgere di malattie cardiovascolari. Natural emulsifier, it keeps the cholesterol present in the blood in suspension, preventing it from settling on the artery wall. It lowers the LDL cholesterol content in the blood, which is the main cause of the onset of cardiovascular diseases.
La lecitina entra a far parte della struttura delle pareti cellulari e rafforza l'azione antiossidante delle vitamine A ed E. Per l’alto contenuto in colina, la lecitina favorisce la metabolizzazione degli acidi grassi nel fegato. Previene inoltre l'affaticamento mentale ed i disturbi della vecchiaia. Lecithin becomes part of the cell wall structure and strengthens the antioxidant action of vitamins A and E. Due to its high choline content, lecithin promotes the metabolization of fatty acids in the liver. It also prevents mental fatigue and old age disorders.
6.2 Latte di soya 6.2 Soy milk
Contiene gli isoflavoni ed altri fitormoni che potenziano l’azione anticolesterolo della lecitina. Gli isoflavoni intervengono inoltre in sinergia con la lecitina nella prevenzione di diverse patologie, come quelle tumorali su prostata e mammella, nel diminuire la sintomatologia legata alla menopausa, e non ultimo contribuiscono efficacemente nell’assimilazione del calcio nel tessuto osseo e nel controllo dell’osteoporosi. Contains isoflavones and other phytohormones that enhance the anti-cholesterol action of lecithin. The isoflavones also intervene in synergy with lecithin in the prevention of various pathologies, such as cancer on the prostate and breast, in decreasing the symptoms related to menopause, and last but not least they contribute effectively in the assimilation of calcium in the bone tissue and in the control of osteoporosis. .
6.3 Omega 3 6.3 Omega 3
I principali acidi grassi omega-3 insaturi presenti nell'olio di pesce sono l'acido eicosapentaenoico (EPA) e l'acido docosaesaenoico (DHA). Sono nutrienti essenziali al metabolismo cellulare e tissutale di organi come occhio e sistema nervoso centrale. Effetti positivi a seguito di uso di Omega3 si sono verificati in casi di infiammazione, artrite reumatoide, ipertensione, asma. Normalmente vengono assunti per diminuire il livello dei trigliceridi ed del colesterolo nel sangue, e ridurre la capacità di aggregazione delle piastrine nel sangue, grazie alla loro attività antitrombotica. The main unsaturated omega-3 fatty acids found in fish oil are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). They are essential nutrients for the cellular and tissue metabolism of organs such as the eye and central nervous system. Positive effects following the use of Omega3 have occurred in cases of inflammation, rheumatoid arthritis, hypertension, asthma. They are normally taken to decrease the level of triglycerides and cholesterol in the blood, and reduce the ability of platelets to aggregate in the blood, thanks to their antithrombotic activity.
6.4 Omega 6 6.4 Omega 6
Sono derivati vegetali che hanno funzioni ed attività analoghe agli Omega3. Ne completano e potenziano l’azione benefica. They are plant derivatives that have functions and activities similar to Omega3. They complement and enhance its beneficial action.
6.5 Shii Take 6.5 Shii Take
Fungo edibile coltivato in tutto il mondo, usato normalmente in cucina sia fresco che secco. Anticolesterolo, fluidificante sanguigno, ipoglicemizzante, ricostituente generale. Edible mushroom grown all over the world, normally used in cooking both fresh and dry. Anti-cholesterol, blood thinner, hypoglycemic, general tonic.
6.6 Fermenti lattici e Lieviti 6.6 Lactic ferments and yeasts
Normalizzano e potenziano la flora microbica intestinale. They normalize and strengthen the intestinal microbial flora.
Aumentano la biodi sponibilita degli alimenti e l’attività biologica dei vari principi attivi impiegati nelle nostre formulazioni. The bioavailability of food and the biological activity of the various active ingredients used in our formulations increase.
6.7 Lvcopene 6.7 Lvcopene
Estratto dalle bucce di pomodoro. Appartiene alla famiglia dei carotenoidi, esercita una’ azione provitaminica, antiossidante, antiradicali liberi. Extracted from tomato peels. It belongs to the carotenoid family, exerts a provitamin, antioxidant, anti-free radical action.
6.8 Te verde 6.8 Green tea
Estratti dalle foglie del tè verde non fermentato Contengono particolari classi di polifenoli, le catechine, epicatechine, ed epigallocathecine, ed esercitano una energica azione antiossidante ed antiradicali liberi. Extracts from unfermented green tea leaves They contain particular classes of polyphenols, catechins, epicatechins, and epigallocathecins, and exert an energetic antioxidant and anti-free radical action.
6.9 Glucomannano e Chitosano 6.9 Glucomannan and Chitosan
Sono fibre vegetali, (radice del koniak) ed animali (carapace di crostacei) rispettivamente, non sono solubili, particolarmente efficaci nel assorbimento dei grassi e nella loro eliminazione dal cibo ingerito. Esercitano un’azione chelante sui metalli pesanti presenti negli alimenti. They are vegetable (koniak root) and animal (shellfish carapace) fibers respectively, they are not soluble, particularly effective in the absorption of fats and in their elimination from ingested food. They exert a chelating action on heavy metals present in food.
6.10 Inulina e Gomma di acacia 6.10 Inulin and Acacia gum
Fibre vegetali solubili, particolarmente efficaci nel corretto sviluppo della flora microbica intestinale. L’inulina si può considerare ima fibra dietetica probiotica. Essa infatti non viene digerita nel tratto intestinale e può raggiungere il colon senza alcun cambiamento. Qui F inulina viene attaccata e fermentata dai lattobacilli presenti, favorendone lo sviluppo. Soluble vegetable fibers, particularly effective in the correct development of the intestinal microbial flora. Inulin can be considered a probiotic dietary fiber. In fact, it is not digested in the intestinal tract and can reach the colon without any change. Here F inulin is attacked and fermented by the lactobacilli present, favoring their development.
Nello stesso tempo la flora microbica potenzialmente patogena come Clostridi e Colibatteri viene sensibilmente ridotta. At the same time, the potentially pathogenic microbial flora such as Clostridia and Colibacteria is significantly reduced.
Recenti studi hanno confermato i seguenti benefici: Recent studies have confirmed the following benefits:
-Riduzione dei trigliceridi ematici -Maggiore biodisponibilita di minerali -Immuno stimolazione aspecifica - Flora microbica del colon potenziata 7. Associazioni sinergiche - Reduction of blood triglycerides - Greater bioavailability of minerals - Immune nonspecific stimulation - Enhanced microbial flora of the colon 7. Synergistic associations
Alcuni esempi di possibili associazioni : * ;1 Lecitina di soya Shii Take 2.Lecitina di soya Omega3 ;3. Lecitina di soya Omegaó 4. Lecitina di soya Lycopene ;5. Lecitina di soya Omega3/6+ Lieviti 6. Lecitina di soya Latte di soya 7. Lecitina di soya Fermenti lattici 8. Lecitina di soya Lieviti 9,Omega3 Omegaó 10.Omega3 Omegaó Lycopene 11.Omega3 Omegaó Shii Take 12.Latte di soya Shii Take Te verde 13. Te verde Lycopene 14.Glucomannano Chitosano 15.Glucomannano+ Inulina ló.Chitosano Acacia gum ;* Quanto sopra riportato non costituisce un esempio limitativo od esclusivo. II presente brevetto copre pertanto tutte le possibili associazioni tra i principi attivi di cui al punto 2, per l’impiego negli alimenti sopra elencati al punto 5. Some examples of possible associations: *; 1 Soya Lecithin Shii Take 2.Soya Lecithin Omega3; 3. Soya Lecithin Omegaó 4. Soya Lecithin Lycopene; 5. Soya lecithin Omega3 / 6 + Yeasts 6. Soya lecithin Soy milk 7. Soya lecithin Lactic ferments 8. Soya lecithin Yeasts 9, Omega3 Omegaó 10.Omega3 Omegaó Lycopene 11.Omega3 Omegaó Shii Take 12.Soy milk Shii Take Green tea 13. Green tea Lycopene 14.Glucomannan Chitosan 15.Glucomannan + Inulin ló.Chitosan Acacia gum; * The above is not a limiting or exclusive example. This patent therefore covers all possible associations between the active ingredients referred to in point 2, for use in the foods listed above in point 5.
8. Dosi d’impiego. 8. Usage doses.
Le dosi di impiego posseggono proprie autolimitazioni dipendenti da: The doses of use have their own self-limitations depending on:
8.1 D gusto e sapore finale 8.1 D taste and final flavor
Non è possibile superare certi limiti in quanto si avrebbe un prodotto finale alterato nel gusto e nel sapore. It is not possible to exceed certain limits as the final product would be altered in taste and flavor.
8.2 L’uso razionale 8.2 Rational use
Gli Omega3 e Omega 6 si impiegano in ragione di parti per migliaia, l-5%o La lecitina in misura di parti per cento, generalmente non eccedente il 3 %. Il latte di soia in misura di parti per cento, dall 1 al 5 % e più. Omega3 and Omega 6 are used in parts per thousand, l-5% or Lecithin in parts per cent, generally not exceeding 3%. Soybean milk in parts per cent, from 1 to 5% and more.
L’estratto de fungo Shii Take, da parti per centinaia nel caso di polveri tal quali, a parti per mille in caso di estratti, da un 2-5 % ad un 3-5 %o. The Shii Take mushroom extract, from parts per hundred in the case of powders as such, to parts per thousand in the case of extracts, from 2-5% to 3-5% o.
Gli antiossidanti in parti per migliaia, mediamente 0.5 - 5 %o Chitosano e glucomannano in percentuali tra 0.5 e 2% Antioxidants in parts per thousand, on average 0.5 - 5% or Chitosan and glucomannan in percentages between 0.5 and 2%
8.3 L’associazione 8.3 The association
Ovvio che in caso di associazioni diverse, la percentuale d’impiego delle singole frazioni verrà proporzionalmente ridotta . Le percentuali d’impiego esemplificate non sono vincolanti e possono variare in dipendenza di fattori diversi quali, tipo di prodotto, destinazione, tipo di materie prime di base impiegate, metodi di cottura e di preparazione ecc. Obviously, in the case of different associations, the percentage of use of the individual fractions will be proportionally reduced. The percentages of use exemplified are not binding and may vary depending on various factors such as the type of product, destination, type of basic raw materials used, cooking and preparation methods, etc.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2000VR000038A ITVR20000038A1 (en) | 2000-05-04 | 2000-05-04 | FUNCTIONAL FOOD PRODUCTS. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2000VR000038A ITVR20000038A1 (en) | 2000-05-04 | 2000-05-04 | FUNCTIONAL FOOD PRODUCTS. |
Publications (2)
Publication Number | Publication Date |
---|---|
ITVR20000038A0 ITVR20000038A0 (en) | 2000-05-04 |
ITVR20000038A1 true ITVR20000038A1 (en) | 2001-11-04 |
Family
ID=11461819
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT2000VR000038A ITVR20000038A1 (en) | 2000-05-04 | 2000-05-04 | FUNCTIONAL FOOD PRODUCTS. |
Country Status (1)
Country | Link |
---|---|
IT (1) | ITVR20000038A1 (en) |
-
2000
- 2000-05-04 IT IT2000VR000038A patent/ITVR20000038A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
ITVR20000038A0 (en) | 2000-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wu et al. | The utility of algae as sources of high value nutritional ingredients, particularly for alternative/complementary proteins to improve human health | |
US11723943B2 (en) | Therapeutic use of chardonnay seed products | |
El Sohaimy | Functional foods and nutraceuticals-modern approach to food science | |
EP2247201B1 (en) | Food products containing omega-3 fatty acids | |
McClements | Ultraprocessed plant‐based foods: Designing the next generation of healthy and sustainable alternatives to animal‐based foods | |
JP2009179622A (en) | Composition for oral administration | |
Oduntan et al. | Design, formulation, and characterization of a potential ‘whole food’using fibre rich orange (Citrus sinensis Lin) pomace as base | |
CN105394122A (en) | Yunnan-style mooncake oil and making method thereof | |
EP3197297B1 (en) | Prebiotic inulin based preparation | |
Jalgaonkar et al. | Nutraceuticals and functional foods | |
Ramesh et al. | Concepts and trends of functional foods: a review | |
JP2017008001A (en) | Retinal protective composition | |
Giacco et al. | Functional Foods: Can Food Technology Help in the Prevention and Treatment of Diabetes? | |
JP5248023B2 (en) | Calcium absorption promoting composition | |
JP7382085B2 (en) | Joint function improvement composition | |
JP2017014164A (en) | Joint function improving composition | |
ITVR20000038A1 (en) | FUNCTIONAL FOOD PRODUCTS. | |
JP6978103B2 (en) | Retinal protection composition | |
EP3723501A1 (en) | Milled flaxseed with turmeric and piperine | |
JP7005043B2 (en) | Retinal protection composition | |
Mittu et al. | Summary of Natural Products in the Nutraceutical Industry | |
Oduntan et al. | orange (Citrus sinensis Lin) pomace as base, Bioactive Carbohydrates and Dietary Fibre, https://doi. org/10.1016/j. bcdf. 2018.10. 001 | |
Joshi et al. | Functional Foods for Geriatrics | |
ITVR20000053A1 (en) | FUNCTIONAL VALUE FOOD COMPLEMENTS. | |
WO2011033884A1 (en) | Prophylactic agent for muscular contracture |